Inhibikase Therapeutics, Inc. — 10-Q Filings
15 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Inhibikase Therapeutics, Inc. (IKT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Inhibikase Therapeutics, Inc. has filed 15 10-Q documents with the SEC since 2018. To view all SEC filings by Inhibikase Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-283169 | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001193125-25-180899 | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-071635 | May 14, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-126766 | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-097022 | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-060579 | May 15, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-063713 | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-042389 | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-021974 | May 15, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-025011 | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-017140 | Aug 12, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-010085 | May 16, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-21-004620 | Nov 15, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-044637 | Aug 16, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-028436 | May 17, 2021 | Mar 31, 2021 |